Quince Therapeutics, Inc.

United States

Last price 31.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.16M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidate comprises eDSP, which is in Phase 3 for the treatment of rare pediatric neurodegenerative diseases, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in the ATM gene. Its AIDE technology platform is a drug/device combination platform that uses an automated process to encapsulate a...